Røseth AG - Search Results

1

[Measurement of calprotectin in faeces].

Jahnsen J, Røseth AG, Aadland E. Jahnsen J, et al. Among authors: roseth ag. Tidsskr Nor Laegeforen. 2009 Apr 16;129(8):743-5. doi: 10.4045/tidsskr.08.0010. Tidsskr Nor Laegeforen. 2009. PMID: 19373299 Free article. Review. Norwegian.

2

Fecal calprotectin concentration in patients with colorectal carcinoma.

Kristinsson J, Røseth A, Fagerhol MK, Aadland E, Schjønsby H, Børmer OP, Raknerud N, Nygaard K. Kristinsson J, et al. Dis Colon Rectum. 1998 Mar;41(3):316-21. doi: 10.1007/BF02237485. Dis Colon Rectum. 1998. PMID: 9514426

3

Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?

Røseth AG, Kristinsson J, Fagerhol MK, Schjønsby H, Aadland E, Nygaard K, Roald B. Røseth AG, et al. Scand J Gastroenterol. 1993 Dec;28(12):1073-6. doi: 10.3109/00365529309098312. Scand J Gastroenterol. 1993. PMID: 8303210

4

Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein.

Røseth AG, Aadland E, Jahnsen J, Raknerud N. Røseth AG, et al. Digestion. 1997;58(2):176-80. doi: 10.1159/000201441. Digestion. 1997. PMID: 9144308

5

Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.

Røseth AG, Fagerhol MK, Aadland E, Schjønsby H. Røseth AG, et al. Scand J Gastroenterol. 1992 Sep;27(9):793-8. doi: 10.3109/00365529209011186. Scand J Gastroenterol. 1992. PMID: 1411288

6

Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.

Røseth AG, Aadland E, Grzyb K. Røseth AG, et al. Scand J Gastroenterol. 2004 Oct;39(10):1017-20. doi: 10.1080/00365520410007971. Scand J Gastroenterol. 2004. PMID: 15513345 No abstract available.

7

Free protein S deficiency in patients with Crohn's disease.

Aadland E, Odegaard OR, Røseth A, Try K. Aadland E, et al. Scand J Gastroenterol. 1994 Apr;29(4):333-5. doi: 10.3109/00365529409094844. Scand J Gastroenterol. 1994. PMID: 8047807

8

Free protein S deficiency in patients with chronic inflammatory bowel disease.

Aadland E, Odegaard OR, Røseth A, Try K. Aadland E, et al. Scand J Gastroenterol. 1992 Nov;27(11):957-60. doi: 10.3109/00365529209000170. Scand J Gastroenterol. 1992. PMID: 1455194

9

Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer.

Kristinsson J, Røseth AG, Sundset A, Nygaard K, Løberg EM, Paulsen JE, Aadland E, Fagerhol MK. Kristinsson J, et al. Among authors: roseth ag. Scand J Gastroenterol. 1999 Dec;34(12):1216-23. doi: 10.1080/003655299750024733. Scand J Gastroenterol. 1999. PMID: 10636069

10

INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial.

Boye B, Lundin KE, Jantschek G, Leganger S, Mokleby K, Tangen T, Jantschek I, Pripp AH, Wojniusz S, Dahlstroem A, Rivenes AC, Benninghoven D, Hausken T, Roseth A, Kunzendorf S, Wilhelmsen I, Sharpe M, Blomhoff S, Malt UF, Jahnsen J. Boye B, et al. Inflamm Bowel Dis. 2011 Sep;17(9):1863-73. doi: 10.1002/ibd.21575. Epub 2011 Feb 1. Inflamm Bowel Dis. 2011. PMID: 21287660 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page